跳至主要内容
临床试验/NL-OMON30660
NL-OMON30660招募中2 期

Stepwise Medical Treatment of Cushing*s Disease: a prospective open label multi-center trial with SOM230 mono- and combination therapy with dopamine agonists and ketoconazole - Stepwise Medical Treatment of Cushing's disease

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 16 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with Cushing's disease, i.e. with hypercortisolism due to an ACTH-producing pituitary adenoma. Eligible for enrolment are: naive patients with Cushing*s disease, patients with residual hypercortisolism after recent transsphenoidal adenomectomy and patients with recurrent Cushing*s disease.

排除标准

  • - Patients with poorly controlled diabetes mellitus indicated by a HbA1c % > 8.5 %.
  • - Patients with a disturbed liver function indicated by serum bilirubin, ALAT, ASAT
  • or alkaline phosphatase levels > 2.5 x ULN.
  • - Patients with renal insufficiency indicated by serum creatinine levels > 2.0 x ULN
  • - Patients with symptomatic cholelithiasis.
  • - Pregnant patients or patients who desire to become pregnant during the study

研究者

相似试验